PRRT1B Inhibitors
PRRT1B inhibitors are chemicals that impede the functional activity of the PRRT1B protein through various signaling pathways. One mechanism by which these inhibitors act is through the suppression of protein kinases that are responsible for the phosphorylation of PRRT1B, ensuring a reduction in its signaling activity. This is achieved by compounds that target key enzymes within the cellular signaling cascade, interrupting the flow of chemical signals and thus leading to inhibited PRRT1B activity. Specifically, the inhibition of the MAPK/ERK pathway, which is crucial for cell proliferation and differentiation, can result in decreased PRRT1B function, as this protein may play a role in these processes.
Moreover, PRRT1B function can also be attenuated by compounds that interfere with the PI3K/Akt and mTOR pathways, both of which are instrumental in regulating cell growth and survival. By dampening these pathways, the phosphorylation state and, consequently, the activity of PRRT1B can be indirectly reduced. Additionally, inhibiting the JNK and p38 MAPK pathways, which are involved in cellular stress and inflammatory responses, may also lead to a decrease in PRRT1B activity. Compounds that target the Rho/ROCK pathway and Src family kinases are also involved in the regulatory network that modulates PRRT1B activity, further expanding the arsenal of molecular strategies to inhibit PRRT1B.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent protein kinase inhibitor that can suppress the phosphorylation of target proteins including PRRT1B, leading to a reduction in its signaling activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A phosphoinositide 3-kinase (PI3K) inhibitor that may downregulate PRRT1B activity through the PI3K/Akt pathway, as PRRT1B function is often modulated by phosphorylation events which are affected by this pathway. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A PI3K inhibitor that impairs the PI3K/Akt signaling pathway potentially leading to decreased PRRT1B activity through reduced phosphorylation. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
A MEK inhibitor that interrupts the MAPK/ERK pathway, which could lead to reduced PRRT1B function due to the dependency of PRRT1B signaling on this pathway for certain cellular processes. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor which can dampen the mTOR signaling pathway, indirectly leading to lowered PRRT1B activity due to the role of mTOR in protein synthesis and cell growth, processes in which PRRT1B may be involved. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A JNK inhibitor that may lead to decreased PRRT1B activity by disrupting the JNK signaling pathway which is implicated in various cellular functions including those that could involve PRRT1B. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor that may reduce PRRT1B activity by inhibiting p38 MAPK-dependent signaling processes, potentially impacting PRRT1B's role in these pathways. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
A Src family kinase inhibitor that could decrease PRRT1B function by hindering Src kinase-mediated signaling, which may be necessary for full PRRT1B activity. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
A ROCK inhibitor that can attenuate the Rho/ROCK pathway, possibly leading to a decrease in PRRT1B activity if PRRT1B is implicated in signaling cascades downstream of Rho/ROCK. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An inhibitor of MEK that could lower PRRT1B activity indirectly by inhibiting the MAPK/ERK pathway, impacting cellular events that may require PRRT1B function. | ||||||